ARMAND G CACCIARELLI

Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology NEW YORK, NY NPI 1962489880

General Payments — all program years on this page

$1,202.56

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 51
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $306.66 across 13 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $306.6613

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ABBVIE INC. $151.257
Takeda Pharmaceuticals U.S.A., Inc. $96.114
Janssen Biotech, Inc. $34.691
Phathom Pharmaceuticals, Inc. $24.611

By program year

Program yearAmountRecords
2018 $80.415
2019 $20.133
2021 $350.0210
2022 $369.1817
2023 $76.163
2024 $306.6613

Records — PY2024 (13)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078449829 Janssen Biotech, Inc. $34.69 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103402437 ABBVIE INC. $23.47 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103402439 ABBVIE INC. $0.38 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103402441 ABBVIE INC. $29.16 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103402443 ABBVIE INC. $30.37 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103402445 ABBVIE INC. $20.74 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103402447 ABBVIE INC. $24.51 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103402449 ABBVIE INC. $22.62 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137500883 Takeda Pharmaceuticals U.S.A., Inc. $30.03 06/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137500887 Takeda Pharmaceuticals U.S.A., Inc. $18.34 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137500891 Takeda Pharmaceuticals U.S.A., Inc. $27.56 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137500894 Takeda Pharmaceuticals U.S.A., Inc. $20.18 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151045070 Phathom Pharmaceuticals, Inc. $24.61 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.